- Country: Canada
- Summary: Compensation and Pay Equity Maintenance Review
- CAT Ref No: 121078480
- Deadline: 09 Jul 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: C-252601320
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- An overview of our requirements is outlined below. For more information and proposal submission instructions, refer to the RFP main document. Additional instructions may get published in bulletins.Canada's federal, provincial, and territorial health care decision makers rely on CDA-AMC to provide them with credible, impartial advice and evidence-based information about the effectiveness of drugs and other health technologies. Our scope includes health technology assessment, the clinical and cost-effectiveness of new drugs, and best practices in drug prescribing and use in Canada.Project 1 Compensation ReviewOur current compensation methodology identifies the maximum of our salary ranges as the 50th percentile of the market we compare ourselves to. Salary increases for employees have been historically applied consistently, and no variable pay structure is currently in place for the majority of our workforce.We are seeking proposals to conduct a comprehensive compensation review. As part of our commitment to attracting and retaining top talent, it is vital to ensure that our compensation practices are competitive, equitable, and aligned with both industry standards and our organizational values. The organization's last compensation review was conducted in our 2022-2023 fiscal year.Project 2 Pay Equity Maintenance ReviewCanada's Drug Agency is subject to Part I of the Pay Equity Act (Ontario). As the organization has evolved over the last several years, there is an appropriate ...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINCompensation and Pay Equity Maintenance Review - Canada Tender
The CANADA'S DRUG AGENCY, a Government sector organization in Canada, has announced a new tender for Compensation and Pay Equity Maintenance Review. This tender is published on CanadaTenders under CAT Ref No: 121078480 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-07-09.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
